A double blind randomized controlled trial was conducted in 71
adolescents aged 11-18 years. Inclusion in the trial required
fulfilment of the diagnostic criteria, (Fukuda et al., 1994).
Three infusions of 1 gm/kg (max 1 litre of 6 gm/100 ml in 10%
w/v maltose solution) were given one month apart. The dummy
solution was a 10% w/v maltose solution with 1% albumin of
equivalent volume for weight. Efficacy was assessed by
difference in a mean functional score including school
attendance, school work, social activity and physical
activity, between baseline, three months and six months after
the final infusion.
Subscribe to the World's Most Popular ME-CFS Newsletter (it's free!)
There was a significant mean functional improvement at
the six month follow-up of 70 adolescents with Chronic
Fatigue Syndrome of average duration 18 months. There
was also a significant improvement for both groups from the
beginning of the trial to the six month post infusion
follow-up. Adverse effects were common with both solutions but
not predictive of response. Neither solution could be
identified by recipients.
MCM: From 1994 AACFS meeting in Ft. Lauderdale